NCT07146425 Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
| NCT ID | NCT07146425 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Huashan Hospital |
| Condition | Myasthenia Gravis |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2023-08-31 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2023-08-31 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research is a single-center, exploratory, observational study to be carried out in the outpatient or inpatient ward of the Neurology Department at Huashan Hospital, affiliated to Fudan University. The aim is to develop a digital assessment model for Myasthenia Gravis by gathering multimodal digital phenotypic data from MG patients. This includes physiological signals, facial videos, eye movements, speech, limb movements, various scales, and quality of life metrics.
Eligibility Criteria
Inclusion Criteria: For Patients with MG * Patients have a confirmed diagnosis of myasthenia gravis and be over 18 years old. * Patients have the clinical classification of Myasthenia Gravis Foundation of America (MGFA) within I-IV, or be asymptomatic after treatment. * Patients must sign the informed consent form and the privacy confidentiality agreement. For Healthy Participants * Age group matched with MG participants Exclusion Criteria: For Patients with MG * Patients are in the crisis stage of myasthenia gravis (MGFA class V) and unable to cooperate with scoring. * Patients are with severe cardiopulmonary diseases and unable to cooperate with the scoring. * Patients with any psychiatric disorder or cognitive dysfunction that, in the investigator's judgment, may interfere with their participation in the study. * Patients with any other unspecified unstable medical condition.
Contact & Investigator
Chongbo Zhao, Ph.D.
PRINCIPAL INVESTIGATOR
Huashan Hospital
Frequently Asked Questions
Who can join the NCT07146425 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Myasthenia Gravis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07146425 currently recruiting?
Yes, NCT07146425 is actively recruiting participants. Contact the research team at himed@fudan.edu.cn for enrollment information.
Where is the NCT07146425 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07146425 clinical trial?
NCT07146425 is sponsored by Huashan Hospital. The principal investigator is Chongbo Zhao, Ph.D. at Huashan Hospital. The trial plans to enroll 180 participants.